## CME: CME Group Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -4.4% below STRENGTH zone (4.0-10.0%); PEG 5.59 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($260.14)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. The Goldman Sachs Group Issues Pessimistic Forecast for CME Group (NASDAQ:CME) Stock Price**
- Source: MarketBeat | 20251206T142754 | Neutral | Relevance: 99%
-  The Goldman Sachs Group has lowered its price target for CME Group (NASDAQ:CME) to $263 from $264, reconfirming a "sell" rating and indicating a potential 3.73% downside. This forecast comes amidst mixed analyst ratings, with the MarketBeat consensus being a "Hold" with an average price target of $289.18. CME Group recently reported a slight EPS beat but a 3% decline in revenue year-over-year.

**2. Nasdaq, S&P 500 Snap Win Streaks as Sentiment Cools**
- Source: Finviz | 20251209T060955 | Somewhat-Bullish | Relevance: 73%
-  The Nasdaq and S&P 500 ended their five-session winning streaks, closing lower as rising bond yields and impending Fed meeting jitters cooled market sentiment. Despite strong odds for a rate cut, the Dow also fell significantly. Commodities like crude oil and gold also experienced pressure due to the upcoming Fed decision and geopolitical tensions.

**3. Miami International Holdings Reports Trading Results for March 2025; Options Volume Jumps 26.8% with MIAX Futures Volume Up 80.4%**
- Source: CBS 42 | 20251207T143134 | Somewhat-Bullish | Relevance: 58%
- Miami International Holdings (MIH) announced strong trading results for March 2025, with multi-listed options volume for the MIAX Exchange Group increasing by 26.8% year-over-year, reaching 173.6 million contracts. MIAX Futures also saw an 80.4% jump in monthly volume, totaling 309,006 contracts. The report highlights record year-to-date volumes for both options and futures, with MIAX Sapphire and MIAX Options achieving record monthly volumes and market shares.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-13 | Piper Sandler | $313 | $296 | +6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-13 | Piper Sandler | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 4 ($7.35M) |
| Sells | 25 ($4.64M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (+0.4%)
- Blackrock Inc.: 8.7% (+4.1%)
- JPMORGAN CHASE & CO: 5.3% (+55.3%)
- State Street Corpora: 4.5% (-2.0%)
- Geode Capital Manage: 2.6% (+2.2%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.9% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $4.6M in recent transactions.
3. Valuation stretched: PEG 5.6x requires aggressive growth execution.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 5.59 signals overvaluation risk, limited margin of safety. Forward P/E 23.2x stretched relative to 4% growth. Quality metrics strong (margin 59%). Analyst sentiment positive (1 raises, avg +6%). Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $97.5B |
| Beta | 0.29 |
| 52W Range | $224.62 - $290.79 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.59 |
| Forward P/E | 23.2 |
| Current P/E | 24.3 |
| YoY Growth | 4.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -1.5% to -4.4% (-2.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.4pp (needs >4.0% for momentum thesis). Underperforming sector by 4.0pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.00x) but short-term weakness (below SMA20). MACD histogram bearish (-1.22), momentum weakening. RSI neutral at 43.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.44% (CS: 20) | Weak |
| RSI_14 | 43.3 | Neutral |
| MACD Histogram | -1.22 | Bearish |
| vs SMA20 | 0.976x | Below |
| vs SMA50 | 0.997x | Below |
| vs SMA200 | 1.001x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $270.42
- **Stop Loss:** $260.14 (3.8% risk)
- **Target:** $280.70 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 97
- **Position Value:** $26,230.74
- **Portfolio %:** 26.23%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-02-11 (Est: $2.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.63 | $2.68 | +2.0% |
| 2025Q2 | $2.94 | $2.96 | +0.6% |
| 2025Q1 | $2.81 | $2.80 | -0.3% |
| 2024Q4 | $2.45 | $2.52 | +3.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*